| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 13 | 2023 | 2326 | 1.610 |
Why?
|
| Kidney Neoplasms | 13 | 2023 | 3022 | 1.450 |
Why?
|
| Pancreatic Neoplasms | 12 | 2024 | 5061 | 0.920 |
Why?
|
| Sickle Cell Trait | 1 | 2023 | 31 | 0.910 |
Why?
|
| Resorcinols | 1 | 2020 | 27 | 0.760 |
Why?
|
| Isoxazoles | 1 | 2020 | 81 | 0.740 |
Why?
|
| SMARCB1 Protein | 4 | 2023 | 109 | 0.710 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 196 | 0.690 |
Why?
|
| Carcinoma, Pancreatic Ductal | 9 | 2023 | 1724 | 0.680 |
Why?
|
| Carcinoma, Medullary | 4 | 2023 | 248 | 0.670 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2020 | 973 | 0.620 |
Why?
|
| Mesoderm | 1 | 2017 | 404 | 0.500 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2023 | 1331 | 0.460 |
Why?
|
| Glioblastoma | 5 | 2021 | 1797 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 8873 | 0.430 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2012 | 42 | 0.430 |
Why?
|
| Rhabdoid Tumor | 2 | 2021 | 110 | 0.340 |
Why?
|
| beta Catenin | 1 | 2012 | 688 | 0.320 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 4821 | 0.310 |
Why?
|
| Genes, ras | 3 | 2021 | 667 | 0.300 |
Why?
|
| Mice | 20 | 2023 | 34495 | 0.300 |
Why?
|
| Dystroglycans | 3 | 2012 | 15 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1130 | 0.280 |
Why?
|
| Transcription Factors | 1 | 2020 | 5270 | 0.280 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2019 | 204 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 3821 | 0.260 |
Why?
|
| Mitochondria | 4 | 2023 | 1282 | 0.250 |
Why?
|
| Animals | 23 | 2023 | 59536 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 1491 | 0.250 |
Why?
|
| Transcriptome | 4 | 2024 | 1859 | 0.230 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 14289 | 0.220 |
Why?
|
| Ecosystem | 1 | 2024 | 111 | 0.220 |
Why?
|
| Neurofibromatosis 2 | 1 | 2023 | 32 | 0.220 |
Why?
|
| Chromosomal Instability | 1 | 2023 | 233 | 0.210 |
Why?
|
| Aneuploidy | 1 | 2023 | 369 | 0.210 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2021 | 6 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 371 | 0.200 |
Why?
|
| Humans | 43 | 2024 | 261506 | 0.200 |
Why?
|
| Acinar Cells | 1 | 2021 | 53 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2021 | 810 | 0.200 |
Why?
|
| Apoptosis | 6 | 2021 | 7591 | 0.190 |
Why?
|
| Biomarkers, Tumor | 6 | 2021 | 10331 | 0.190 |
Why?
|
| Leukotrienes | 1 | 2020 | 14 | 0.190 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 157 | 0.190 |
Why?
|
| Hypoxia | 1 | 2023 | 443 | 0.180 |
Why?
|
| Meningioma | 1 | 2023 | 289 | 0.180 |
Why?
|
| Karyopherins | 1 | 2021 | 136 | 0.180 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 209 | 0.180 |
Why?
|
| Cell Proliferation | 8 | 2021 | 7226 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 848 | 0.170 |
Why?
|
| Pancreatitis | 1 | 2021 | 267 | 0.170 |
Why?
|
| DNA Copy Number Variations | 2 | 2023 | 1516 | 0.170 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2021 | 430 | 0.170 |
Why?
|
| Meningeal Neoplasms | 1 | 2023 | 441 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2012 | 2947 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 5395 | 0.160 |
Why?
|
| Antigens, CD | 3 | 2016 | 1385 | 0.160 |
Why?
|
| Proteostasis | 1 | 2019 | 52 | 0.160 |
Why?
|
| Deoxycytidine | 3 | 2021 | 1353 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2018 | 77 | 0.160 |
Why?
|
| Pancreas | 1 | 2021 | 718 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2012 | 747 | 0.150 |
Why?
|
| Mice, Nude | 3 | 2020 | 4307 | 0.150 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 14551 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 3552 | 0.150 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2017 | 19 | 0.150 |
Why?
|
| Carcinogenesis | 2 | 2021 | 1026 | 0.150 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 318 | 0.150 |
Why?
|
| Malate Dehydrogenase | 1 | 2017 | 21 | 0.150 |
Why?
|
| Prognosis | 8 | 2021 | 21713 | 0.140 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2017 | 142 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 521 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 591 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2020 | 649 | 0.140 |
Why?
|
| RNA | 1 | 2021 | 1013 | 0.140 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 45 | 0.140 |
Why?
|
| DNA Replication | 1 | 2020 | 744 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 4757 | 0.140 |
Why?
|
| DNA Damage | 2 | 2021 | 1954 | 0.130 |
Why?
|
| Recombinational DNA Repair | 1 | 2016 | 79 | 0.130 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2020 | 661 | 0.130 |
Why?
|
| Peptides | 2 | 2012 | 1479 | 0.130 |
Why?
|
| DNA End-Joining Repair | 1 | 2016 | 86 | 0.130 |
Why?
|
| Genes, myc | 1 | 2017 | 358 | 0.130 |
Why?
|
| Endonucleases | 1 | 2016 | 178 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 3101 | 0.130 |
Why?
|
| Mosaicism | 1 | 2017 | 272 | 0.130 |
Why?
|
| Autophagy | 2 | 2019 | 927 | 0.130 |
Why?
|
| Proteolysis | 1 | 2017 | 370 | 0.130 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 962 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 363 | 0.120 |
Why?
|
| raf Kinases | 1 | 2014 | 81 | 0.120 |
Why?
|
| Kidney | 1 | 2023 | 2146 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2012 | 1064 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 107 | 0.120 |
Why?
|
| Mutation | 6 | 2021 | 15179 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2021 | 1664 | 0.110 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 3154 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2012 | 1390 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 461 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 5178 | 0.110 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 1960 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 323 | 0.110 |
Why?
|
| Genes, Essential | 1 | 2012 | 48 | 0.110 |
Why?
|
| Histone Deacetylase 1 | 1 | 2012 | 62 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.110 |
Why?
|
| Cimicifuga | 1 | 2012 | 2 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.110 |
Why?
|
| Fibroadenoma | 1 | 2012 | 25 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2015 | 560 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2015 | 4078 | 0.100 |
Why?
|
| Telomere | 1 | 2015 | 505 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 3719 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2017 | 1442 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 198 | 0.100 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 677 | 0.100 |
Why?
|
| Brain Neoplasms | 3 | 2013 | 4849 | 0.100 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1249 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2012 | 110 | 0.100 |
Why?
|
| Patient Selection | 1 | 2018 | 2055 | 0.090 |
Why?
|
| Cytokines | 1 | 2020 | 2809 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2021 | 1879 | 0.090 |
Why?
|
| Butyrates | 1 | 2010 | 57 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2012 | 576 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 1029 | 0.090 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2012 | 221 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2012 | 215 | 0.090 |
Why?
|
| Signal Transduction | 7 | 2021 | 11965 | 0.090 |
Why?
|
| Diacylglycerol Kinase | 1 | 2009 | 23 | 0.090 |
Why?
|
| Protein Binding | 2 | 2016 | 3438 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 287 | 0.090 |
Why?
|
| Female | 14 | 2023 | 141928 | 0.090 |
Why?
|
| Biocatalysis | 2 | 2021 | 63 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2012 | 875 | 0.090 |
Why?
|
| Digitoxin | 1 | 2008 | 13 | 0.080 |
Why?
|
| Saponins | 1 | 2008 | 34 | 0.080 |
Why?
|
| Cellular Reprogramming | 2 | 2021 | 189 | 0.080 |
Why?
|
| Triterpenes | 1 | 2008 | 61 | 0.080 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2008 | 48 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 2403 | 0.080 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 132 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 476 | 0.080 |
Why?
|
| DNA | 1 | 2016 | 2693 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2330 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 1283 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 850 | 0.070 |
Why?
|
| HT29 Cells | 2 | 2021 | 159 | 0.070 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 5159 | 0.070 |
Why?
|
| Melanoma | 2 | 2014 | 5317 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 803 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2012 | 2450 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1493 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 3578 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 987 | 0.070 |
Why?
|
| Indoles | 2 | 2021 | 1009 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5710 | 0.060 |
Why?
|
| Phospholipid Ethers | 1 | 2023 | 13 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 1506 | 0.060 |
Why?
|
| Male | 10 | 2021 | 123000 | 0.060 |
Why?
|
| Genomics | 3 | 2021 | 2738 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 1678 | 0.060 |
Why?
|
| Biology | 1 | 2023 | 75 | 0.060 |
Why?
|
| Transfection | 2 | 2020 | 2944 | 0.050 |
Why?
|
| Glutaminase | 1 | 2022 | 47 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 4053 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2020 | 1313 | 0.050 |
Why?
|
| Phospholipids | 1 | 2023 | 177 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 15862 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 2979 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2021 | 66 | 0.050 |
Why?
|
| RNA Interference | 2 | 2021 | 1408 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 1399 | 0.050 |
Why?
|
| AC133 Antigen | 2 | 2012 | 110 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 5637 | 0.050 |
Why?
|
| Sulfonamides | 2 | 2021 | 1823 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2021 | 67 | 0.050 |
Why?
|
| Base Sequence | 3 | 2016 | 4917 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 2291 | 0.050 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2020 | 23 | 0.050 |
Why?
|
| Tosyl Compounds | 1 | 2020 | 40 | 0.050 |
Why?
|
| Glutamine | 1 | 2022 | 299 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 2864 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 222 | 0.050 |
Why?
|
| Phenylcarbamates | 1 | 2020 | 25 | 0.050 |
Why?
|
| Sulfides | 1 | 2020 | 48 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2016 | 6089 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2020 | 88 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 118 | 0.050 |
Why?
|
| HCT116 Cells | 1 | 2021 | 348 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 82 | 0.050 |
Why?
|
| Acetates | 1 | 2020 | 105 | 0.050 |
Why?
|
| Carboplatin | 1 | 2023 | 823 | 0.050 |
Why?
|
| Metaplasia | 1 | 2021 | 383 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 2020 | 204 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 216 | 0.040 |
Why?
|
| Morpholines | 1 | 2021 | 289 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2021 | 1823 | 0.040 |
Why?
|
| Intestinal Fistula | 1 | 2019 | 44 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 7222 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 905 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 170 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1443 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2022 | 480 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 115 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 2216 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2021 | 448 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 950 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 745 | 0.040 |
Why?
|
| Proteasome Inhibitors | 1 | 2019 | 231 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 4988 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 7789 | 0.040 |
Why?
|
| Quinolines | 1 | 2020 | 383 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2017 | 38 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 32 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 1869 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cell Survival | 2 | 2014 | 3045 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2019 | 253 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 544 | 0.040 |
Why?
|
| Transaminases | 1 | 2017 | 76 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 657 | 0.040 |
Why?
|
| NADP | 1 | 2017 | 96 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 110 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2017 | 94 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 673 | 0.040 |
Why?
|
| Geminin | 1 | 2016 | 9 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2012 | 6207 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 268 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 942 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 169 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2016 | 98 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 3230 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 793 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 171 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2019 | 351 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1987 | 0.030 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2015 | 88 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 274 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 123 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1129 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 52 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 15193 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 686 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2021 | 3005 | 0.030 |
Why?
|
| Cisplatin | 1 | 2021 | 2432 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 1048 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2016 | 288 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 37905 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 1818 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2021 | 9180 | 0.030 |
Why?
|
| Pyridines | 1 | 2021 | 1244 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 413 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 1022 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 395 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 557 | 0.030 |
Why?
|
| Plasmids | 1 | 2016 | 837 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 3536 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 316 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2015 | 294 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 370 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 253 | 0.030 |
Why?
|
| Recurrence | 2 | 2014 | 4758 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 18 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 492 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 660 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 1299 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 2359 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 87 | 0.030 |
Why?
|
| Piperazines | 1 | 2021 | 2101 | 0.030 |
Why?
|
| Lysosomes | 1 | 2014 | 347 | 0.030 |
Why?
|
| Doxycycline | 1 | 2012 | 178 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 2488 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 1489 | 0.030 |
Why?
|
| Glycolysis | 1 | 2014 | 519 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 6295 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2218 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 327 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 278 | 0.020 |
Why?
|
| Neoplasm Staging | 3 | 2012 | 13658 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 854 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 1555 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 717 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 213 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 4320 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2014 | 1090 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2010 | 6150 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 442 | 0.020 |
Why?
|
| DNA Methylation | 2 | 2010 | 2669 | 0.020 |
Why?
|
| Proteome | 1 | 2013 | 561 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1165 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2020 | 2819 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2012 | 428 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 1519 | 0.020 |
Why?
|
| Middle Aged | 5 | 2019 | 86204 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2009 | 188 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2021 | 3518 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2012 | 10001 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 1546 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 591 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 6942 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2054 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 9244 | 0.020 |
Why?
|
| Aged | 4 | 2019 | 70117 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 3254 | 0.020 |
Why?
|
| Italy | 1 | 2007 | 236 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 280 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 2063 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 1487 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2007 | 178 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 32848 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 1547 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 6682 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 1620 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 2074 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 15694 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 3343 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 77950 | 0.010 |
Why?
|
| Rats | 1 | 2012 | 6086 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3639 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 4938 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 4892 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2008 | 1549 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 3570 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 7548 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 29902 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 12926 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 10035 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 21445 | 0.010 |
Why?
|